Vertex Pharmaceuticals's total assets for Q2 2025 were $24.04B, an increase of 5.05% from the previous quarter. VRTX total liabilities were $6.86B for the fiscal quarter, a 7.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.